This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday – Ascendis Pharma (NASDAQ:ASND), Anteris Technologies (NASDAQ:AVR)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Piper Sandler analyst Mike Lavery initiated coverage on The Coca-Cola Company KO with an Overweight rating and announced a price target of $74. Coca-Cola shares closed at $60.81 on Monday. See how other analysts view this stock.
• Truist Securities analyst John McDonald initiated coverage on JPMorgan Chase & Co. JPM with a Hold rating and announced a price target of $260. JPMorgan shares closed at $240.85 on Tuesday. See how other analysts view this stock.
• RBC Capital analyst Sean Dodge initiated coverage on ICON Public Limited Company ICLR with an Outperform rating and announced a price target of $263. Icon shares closed at $215.51 on Monday. See how other analysts view this stock.
• UBS analyst Eliana Merle initiated coverage on Ascendis Pharma A/S ASND with a Buy rating and announced a price target of $196. Ascendis Pharma shares closed at $140.28 on Monday. See how other analysts view this stock.
• Cantor Fitzgerald analyst Ross Osborn initiated coverage on Anteris Technologies Global Corp. AVR with an Overweight rating and announced a price target of $9. Anteris Technologies shares closed at $5.61 on Monday. See how other analysts view this stock.

Considering buying KO stock? Here’s what analysts think:

Read This Next:

• Wells Fargo Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street’s Most Accurate Analysts

NewsInitiationPre-Market OutlookMarketsAnalyst RatingsTrading IdeasTop Initiations